Eton Pharmaceuticals Inc
NASDAQ:ETON

Watchlist Manager
Eton Pharmaceuticals Inc Logo
Eton Pharmaceuticals Inc
NASDAQ:ETON
Watchlist
Price: 16.83 USD -0.94% Market Closed
Market Cap: 451.4m USD

Wall Street
Price Targets

ETON Price Targets Summary
Eton Pharmaceuticals Inc

Wall Street analysts forecast ETON stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ETON is 30.6 USD with a low forecast of 26.26 USD and a high forecast of 36.75 USD.

Lowest
Price Target
26.26 USD
56% Upside
Average
Price Target
30.6 USD
82% Upside
Highest
Price Target
36.75 USD
118% Upside
Eton Pharmaceuticals Inc Competitors:
Price Targets
300363
Porton Pharma Solutions Ltd
30% Upside
TRUL
Trulieve Cannabis Corp
79% Upside
200670
Humedix Co Ltd
76% Upside
RPRX
Royalty Pharma PLC
18% Upside
SANOFI
Sanofi India Ltd
23% Upside
4507
Shionogi & Co Ltd
4% Downside
1J5
Hyphens Pharma International Ltd
23% Upside
AZN
AstraZeneca PLC
7% Upside

Revenue
Forecast

Revenue Estimate
Eton Pharmaceuticals Inc

The compound annual growth rate of Eton Pharmaceuticals Inc's revenue for the next 4 years is 51%.

N/A
Past Growth
51%
Estimated Growth
Estimates Accuracy
-12%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Eton Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-12%
Average Miss

Net Income
Forecast

Net Income Estimate
Eton Pharmaceuticals Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-16%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ETON's stock price target?
Price Target
30.6 USD

According to Wall Street analysts, the average 1-year price target for ETON is 30.6 USD with a low forecast of 26.26 USD and a high forecast of 36.75 USD.

What is Eton Pharmaceuticals Inc's Revenue forecast?
Projected CAGR
51%

The compound annual growth rate of Eton Pharmaceuticals Inc's revenue for the next 4 years is 51%.

Back to Top